Please login to the form below
RandD productivity
This page shows the latest RandD productivity news and features for those working in and with pharma, biotech and healthcare.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Senior Medical Writer
-
Competitive Salary
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Associate Account Director
-
Competitive Salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Medical Editor
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
-
Publications Director
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior & Principal Medical Writer
-
Competitive Salary Offered
-
Account Management
-
Competitive Salary Offered
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
-
Account Manager
-
Competitive Salary
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- Merck & Co reveals plans for women’s health spinoff Organon
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- bluebird bio aiming to separate business units by year-end
- AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
- Sharing patient stories for World Pulmonary Hypertension Day
- AZ, Daiichi Sankyo reveal new TNBC data for next-gen antibody drug conjugate
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- China’s Sinopharm given WHO emergency use listing for COVID-19 vaccine
- Pfizer, BioNTech file for full US approval of COVID-19 vaccine
- The impact of cancer on mental health during COVID-19
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
- The new reality of building a corporate brand in pharma
- FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
PMHub
certain health
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...
Latest intelligence
- Sharing patient stories for World Pulmonary Hypertension Day
- For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
- How nature can help you manage the pressures of agency life
- Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
